s6y
Company name or ticker
Search
Nurix Therapeutics, Inc.
POS EX
Post-effective amendment filed solely to add exhibits to a registration statement
Filed
Friday, March 5, 2021
Accession number
0001193125-21-071442
Documents
Post-effective amendment filed solely to add exhibits to a registration statement
POS EX
Certifications, consents and other formalities
1
Legal opinion
5.1
Legal opinion
EX-5.1
On sec.gov
Filing index
All files
Complete submission text
SGML header